| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be8a700e110cdb66efebd6853677babd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e8789ebc2a0d680adcea29ff5f7094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34cb94ba6548b9b169495c17d94fed6 |
| publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015011204-A1 |
| titleOfInvention |
Serum for treating diseases |
| abstract |
The invention relates to a method for the in-vitro formation and enrichment of interleukin-1-receptor-antagonists (in short: IL-1-Ra) for treating diseases, and to the use thereof, in particular as a cosmetic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017078532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091670-B2 |
| priorityDate |
2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |